source
- STAT+: Intellia says CRISPR-based treatment for rare disease reduced swelling attacks in pivotal trialWith good results from Intellia, the CRISPR field faces the question: How attractive will the one-and-done approach be to patients and doctors?STAT · 3mo ago↗ source
- STAT+: Veradermics’ hair loss drug succeeds in late-stage trialThe company is one of the most advanced players in the hair loss field, which has seen a surge of investor enthusiasm.STAT · 3mo ago↗ source
- STAT+: Oruka’s long-acting psoriasis therapy posts strong results in mid-stage studyA long-acting injectable treatment for plaque psoriasis helped 63% of patients achieve complete skin clearance in a clinical trial, its maker, Oruka Therapeutics, reported.STAT · 3mo ago